|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C08B 37/00 | |
| B01D 15/08 |
| (11) | Patento numeris | 1720912 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05715947.7 |
| Europos patento paraiškos padavimo data | 2005-02-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-11-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2005/002575 |
| Data | 2005-02-18 |
| (87) | Numeris | WO 2005/080438 |
| Data | 2005-09-01 |
| (30) | Numeris | Data | Šalis |
| 0401810 | 2004-02-24 | FR | |
| 04290789 | 2004-03-24 | EP |
| (72) |
MOURIER, Pierre, FR
VISKOV, Christian, FR
|
| (73) |
Aventis Pharma S.A.,
20, avenue Raymond Aron, 92160 Antony,
FR
|
| (54) | Method for determining specific groups constituting heparins or low molecular weight heparins using reversed phase column chromatography |
| Method for determining specific groups constituting heparins or low molecular weight heparins using reversed phase column chromatography |